Hypertension and diabetes in obesity. - Wikidata - awgldk - TriplyDB

Hypertension and diabetes in obesity.

Hypertension and diabetes in obesity.

http://www.wikidata.org/entity/Q42002198

about

Frequency and co-prescription pattern of Chinese herbal products for hypertension in Taiwan: a Cohort study.Trends in the treatment of hypertension from the perspective of traditional chinese medicine.

P2860

Q35654926-881099A1-2C0C-4E16-953A-BB3994AF5E6D Q37009873-F74450E1-7744-449B-98ED-C303C584DFDC

P2860

Hypertension and diabetes in obesity.

http://www.wikidata.org/entity/Q42002198

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Hypertension and diabetes in obesity.

@en

Hypertension and diabetes in obesity.

@nl

type

label

Hypertension and diabetes in obesity.

@en

Hypertension and diabetes in obesity.

@nl

prefLabel

Hypertension and diabetes in obesity.

@en

Hypertension and diabetes in obesity.

@nl

P1433

Q42002198-B74264BE-9F5B-4153-BCAA-C01A7976A638

P1476

Q42002198-4B4B45BC-3DA6-43B7-95DA-3C931D21603B

P2093

Q42002198-2494832B-2642-4AEA-938E-F72ACA928680

Q42002198-2FF57B54-266E-4C1C-A2AE-E0BE9BF2D1F6

Q42002198-35F398DC-F719-4178-AE10-B9280B5A55FC

P2860

Q42002198-0CDF9FF0-BD52-4638-BE06-366132A5385E

Q42002198-0D99F373-7655-4CA5-B6F6-E6A607525D6A

Q42002198-1EC17F13-4B5F-4D95-B8CC-23A663540A96

Q42002198-32910A65-8A15-4434-9B3D-ECA2057A026C

Q42002198-346BD748-2A0B-4B47-84D4-D718494733F8

Q42002198-3C891A05-C0FF-44E4-9759-7225BEB8EB0C

Q42002198-77409D36-F73B-4825-960E-B5475FCE7CEF

Q42002198-92E48B74-6EF5-4CD7-BAEF-BE82176A45CD

Q42002198-BEDEC96C-969A-43E5-A110-D0340A0C7E02

P304

Q42002198-1B1C62F4-403F-4264-82FF-31095B727512

P31

Q42002198-23DFC142-4A9C-493E-9D54-634804CE3FDB

Q42002198-e6fd9798-6271-4ea0-9162-60a57382e8b0

P356

Q42002198-7014306C-CE7E-46B5-AA61-279898949573

P478

Q42002198-97895AA0-A5AA-447F-B133-D724959162EA

P577

Q42002198-F95CA261-A526-4AAC-B6A8-2524B365D9B9

P5875

Q42002198-F89E3951-E119-4A98-B22F-006FA31D2D8A

P698

Q42002198-25F428D6-4C17-494A-925B-1BF9B55CAEA8

P932

Q42002198-CE1C406D-32F1-4945-B7E4-8D50C56B5973

P356

P1433

International Journal of Hypertension

P1476

Hypertension and diabetes in obesity.

@en

P2093

Gavin W Lambert

http://www.w3.org/2001/XMLSchema#string

Kazuko Masuo

http://www.w3.org/2001/XMLSchema#string

Michael L Tuck

http://www.w3.org/2001/XMLSchema#string

P2860

Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001

Roles of beta2- and beta3-adrenoceptor polymorphisms in hypertension and metabolic syndrome.

Obesity-related hypertension: role of the sympathetic nervous system, insulin, and leptin.

Mechanisms of sympathetic activation in obesity-related hypertension.

Mediators of sympathetic activation in metabolic syndrome obesity.

The role of sympathetic nervous activity in renal injury and end-stage renal disease.

Noradrenaline release and the pathophysiology of primary human hypertension.

Sympathetic nervous system activity is associated with obesity-induced subclinical organ damage in young adults.

HOMA insulin sensitivity index and the risk of all-cause mortality and cardiovascular disease events in the general population: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab) study.

P304

695869

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4061/2011/695869

http://www.w3.org/2001/XMLSchema#string

P478

2011

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51484590

http://www.w3.org/2001/XMLSchema#string

P698

21747982

http://www.w3.org/2001/XMLSchema#string

P932

3124686

http://www.w3.org/2001/XMLSchema#string